Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:974870.
doi: 10.1155/2015/974870. Epub 2015 Oct 4.

Clinical Outcome of Hypertensive Uveitis

Affiliations

Clinical Outcome of Hypertensive Uveitis

Deborah Lewkowicz et al. J Ophthalmol. 2015.

Abstract

Purpose. To review the clinical outcome of patients with hypertensive uveitis. Methods. Retrospective review of uveitis patients with elevated intraocular pressure (IOP) > 25 mmHg and >1-year follow-up. Data are uveitis type, etiology, viral (VU) and nonviral uveitis (NVU), IOP, and medical and/or surgical treatment. Results. In 61 patients, IOP values are first 32.9 mmHg (SD: 9.0), highest 36.6 mmHg (SD: 9.9), 3 months after the first episode 19.54 mmHg (SD: 9.16), and end of follow-up 15.5 mmHg (SD: 6.24). Patients with VU (n = 25) were older (50.6 y/35.7 y, p = 0.014) and had more unilateral disease (100%/72.22% p = 0.004) than those with NVU (n = 36). Thirty patients (49.2%) had an elevated IOP before topical corticosteroid treatment. Patients with viral uveitis might have higher first elevated IOP (36.0/27.5 mmHg, p = 0,008) and maximal IOP (40.28/34.06 mmHg, p = 0.0148) but this was not significant when limited to the measurements before the use of topical corticosteroids (p = 0.260 and 0.160). Glaucoma occurred in 15 patients (24.59%) and was suspected in 11 (18.03%) without difference in viral and nonviral groups (p = 0.774). Conclusion. Patients with VU were older and had more unilateral hypertensive uveitis. Glaucoma frequently complicates hypertensive uveitis. Half of the patients had an elevated IOP before topical corticosteroid treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 2
Figure 2

References

    1. Moorthy R. S., Mermoud A., Baerveldt G., Minckler D. S., Lee P. P., Rao N. A. Glaucoma associated with uveitis. Survey of Ophthalmology. 1997;41(5):361–394. doi: 10.1016/s0039-6257(97)00006-4. - DOI - PubMed
    1. Markomichelakis N. N., Kostakou A., Halkiadakis I., Chalkidou S., Papakonstantinou D., Georgopoulos G. Efficacy and safety of latanoprost in eyes with uveitic glaucoma. Graefe's Archive for Clinical and Experimental Ophthalmology. 2009;247(6):775–780. doi: 10.1007/s00417-009-1036-3. - DOI - PubMed
    1. Sung V. C. T., Barton K. Management of inflammatory glaucomas. Current Opinion in Ophthalmology. 2004;15(2):136–140. doi: 10.1097/00055735-200404000-00014. - DOI - PubMed
    1. Kuchtey R. W., Lowder C. Y., Smith S. D. Glaucoma in patients with ocular inflammatory disease. Ophthalmology Clinics of North America. 2005;18(3):421–430. doi: 10.1016/j.ohc.2005.05.004. - DOI - PubMed
    1. Cochereau I. Glaucome et uveite en pratique. Journal Français d'Ophtalmologie. 2003;26(2):S10–S12. - PubMed

LinkOut - more resources